{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:50:46Z","timestamp":1791298246762,"version":"4.1.0"},"reference-count":65,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG003991"],"award-info":[{"award-number":["AG003991"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG066444"],"award-info":[{"award-number":["AG066444"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG02627"],"award-info":[{"award-number":["AG02627"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS097799"],"award-info":[{"award-number":["NS097799"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS075321"],"award-info":[{"award-number":["NS075321"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS097437"],"award-info":[{"award-number":["NS097437"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS110436"],"award-info":[{"award-number":["NS110436"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp; Dementia"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION<\/jats:title>\n                    <jats:p>People with Parkinson's disease (PD) frequently develop dementia. We investigated the relationship between cognitive impairment and the loss of cholinergic axon projections from the nucleus basalis of Meynert to neocortical regions in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Levels of choline acetyltransferase (ChAT), the enzyme required for acetylcholine synthesis, were measured with a sandwich enzyme\u2010linked immunosorbent assay (ELISA) in eight brain regions from 37 PD autopsy cases. Analyses focused on relationships between measures of global cognitive impairment and average ChAT levels in four neocortical regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Mean neocortical ChAT levels positively correlated with the Mini\u2010Mental State Examination and a global cognition z\u2010score obtained by averaging performance in multiple cognitive domains. Mean neocortical ChAT levels also showed a trending inverse correlation with the Clinical Dementia Rating sum of boxes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>These results indicate a role for the loss of cholinergic projections to neocortical regions in the development of cognitive impairment in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/alz.71868","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:54:36Z","timestamp":1791294876000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognitive impairment in Parkinson disease correlates with loss of cholinergic axon projections to cortex in an autopsy study"],"prefix":"10.1002","volume":"22","author":[{"given":"Rebecca","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"O'Shea","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Rosok","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Franklin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Perrin","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Department of Pathology and Immunology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Knight Alzheimer Disease Research Center Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruva","family":"Dhavale","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Perlmutter","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Department of Radiology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Department of Neuroscience Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Program in Occupational Therapy Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan C.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Department of Radiology Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-114X","authenticated-orcid":false,"given":"Paul","family":"Kotzbauer","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Hope Center for Neurological Disorders Washington University School of Medicine  St. Louis Missouri USA"},{"name":"Department of Developmental Biology Washington University School of Medicine  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner CM","year":"2024","journal-title":"N Engl J Med"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.661973","article-title":"Where dopaminergic and cholinergic systems interact: a gateway for tuning neurodegenerative disorders","volume":"15","author":"Amalric M","year":"2021","journal-title":"Front Behav Neurosci"},{"issue":"2","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1176\/appi.neuropsych.21040103","article-title":"Possible contribution of altered cholinergic activity in the visual cortex in visual hallucinations in Parkinson's disease","volume":"34","author":"Sinclair L","year":"2021","journal-title":"J Neuropsychiat Clin Neurosci"},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease","volume":"141","author":"Schulz J","year":"2018","journal-title":"Brain"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.28360","article-title":"Cholinergic denervation patterns across cognitive domains in Parkinson's disease","volume":"36","author":"Zee S","year":"2021","journal-title":"Mov Disord"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2021.07.024","article-title":"Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease","volume":"90","author":"Barrett MJ","year":"2021","journal-title":"Parkins Relat Disord"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","article-title":"Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders","volume":"514","author":"Kotagal V","year":"2012","journal-title":"Neurosci Lett"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mds.28453","article-title":"Cholinergic basal forebrain volumes predict gait decline in Parkinson's disease","volume":"36","author":"Wilson J","year":"2021","journal-title":"Mov Disord"},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mds.26061","article-title":"Clinical markers for identifying cholinergic deficits in Parkinson's disease","volume":"30","author":"M\u00fcller MLTM","year":"2015","journal-title":"Mov Disord"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neurobiolaging.2005.02.004","article-title":"Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism","volume":"27","author":"Ziabreva I","year":"2006","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11682-021-00481-0","article-title":"Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson's disease","volume":"16","author":"Berlot R","year":"2022","journal-title":"Brain Imag Behav"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.723948","article-title":"Altered cortical cholinergic network in Parkinson's disease at different stage: a resting\u2010state fMRI study","volume":"13","author":"Sheng W","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2010.11.015","article-title":"Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status","volume":"33","author":"Choi SH","year":"2012","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","article-title":"The fate of the brain cholinergic neurons in neurodegenerative diseases","volume":"1670","author":"Pepeu G","year":"2017","journal-title":"Brain Res"},{"key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1\u2010Ch6)","volume":"10","author":"Mesulam MM","year":"1983","journal-title":"Neuroscience"},{"key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse PJ","year":"1983","journal-title":"Ann Neurol"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neurobiolaging.2006.02.009","article-title":"MR features of the substantia innominata and therapeutic implications in dementias","volume":"28","author":"Hanyu H","year":"2007","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2021.05.027","article-title":"In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: imaging results from the COPPADIS study","volume":"88","author":"Grothe MJ","year":"2021","journal-title":"Parkinson Relat Disord"},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.neurobiolaging.2009.11.006","article-title":"MRI\u2010based volumetric measurement of the substantia innominata in amnestic MCI and mild AD","volume":"32","author":"George S","year":"2011","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/awx310","article-title":"In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease","volume":"141","author":"Ray NJ","year":"2018","journal-title":"Brain"},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104831","article-title":"Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease","volume":"139","author":"Pereira JB","year":"2020","journal-title":"Neurobiol Dis"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(91)90682-L","article-title":"Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co\u2010localization with cholinergic neurons","volume":"539","author":"Mufson EJ","year":"1991","journal-title":"Brain Res"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease","volume":"137","author":"Hall H","year":"2014","journal-title":"Brain"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004010100372","article-title":"Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment","volume":"102","author":"Mattila PM","year":"2001","journal-title":"Acta Neuropathol"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry EK","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(83)90096-3","article-title":"A subcortico\u2010cortical cholinergic system is affected in Parkinson's disease","volume":"288","author":"Dubois B","year":"1983","journal-title":"Brain Res"},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(82)90615-1","article-title":"Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia","volume":"232","author":"Ruberg M","year":"1982","journal-title":"Brain Res"},{"key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-510X(89)90042-7","article-title":"Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease","volume":"90","author":"Sirvi\u00f6 J","year":"1989","journal-title":"J Neurol Sci"},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acn3.246","article-title":"Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease","volume":"2","author":"Buddhala C","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acn3.51482","article-title":"Quantifying regional \u03b1 \u2010synuclein, amyloid \u03b2, and tau accumulation in lewy body dementia","volume":"9","author":"Miller RL","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease\u2010related pathology","volume":"318","author":"Braak H","year":"2004","journal-title":"Cell Tissue Res"},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jalz.2010.03.012","article-title":"Alzheimer's disease neuroimaging I. Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core","volume":"6","author":"Cairns NJ","year":"2010","journal-title":"Alzheimer's Dement"},{"key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb DJ","year":"1999","journal-title":"Arch Neurol"},{"key":"e_1_2_11_35_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico\u2010pathological study of 100 cases","volume":"55","author":"Hughes AJ","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris JC","year":"1997","journal-title":"Int Psychogeriat\/IPA"},{"key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease\u2010associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak H","year":"2006","journal-title":"Acta Neuropathol"},{"key":"e_1_2_11_38_1","first-page":"293","volume-title":"Recent Developments in Parkinson's Disease","author":"Fahn SM","year":"1987"},{"key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre M","year":"2007","journal-title":"Mov Disord"},{"key":"e_1_2_11_40_1","volume-title":"Wechsler adult intelligence scale\u2010III","author":"Wechsler D","year":"1997"},{"key":"e_1_2_11_41_1","volume-title":"California Verbal Learning Test","author":"Delis DC","year":"2000"},{"key":"e_1_2_11_42_1","volume-title":"WMS\u2010III: Wechsler Memory Scale Administration and Scoring Manual","author":"Wechsler D","year":"1997"},{"key":"e_1_2_11_43_1","volume-title":"Boston naming test","author":"Kaplan E","year":"2001"},{"key":"e_1_2_11_44_1","volume-title":"Neuropsychological Assessment","author":"Lezak MD","year":"2004"},{"key":"e_1_2_11_45_1","unstructured":"WoodcockRW McGrewKS MatherN Woodcock\u2010Johnson III tests of achievement.Itasca IL:Riverside Pub;2001."},{"key":"e_1_2_11_46_1","volume-title":"Neuropsychological Assessment","author":"Lezak MD","year":"1995"},{"key":"e_1_2_11_47_1","article-title":"Delis\u2010Kaplan executive function system (DKEFS)","author":"Delis DC","year":"2001","journal-title":"Psychological Corporation"},{"key":"e_1_2_11_48_1","first-page":"7859","article-title":"The Alzheimer's disease neuroimaging initiative neuropathology core: an update","volume":"20","author":"Perrin RJ","year":"2024","journal-title":"Association"},{"key":"e_1_2_11_49_1","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251315913","article-title":"An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids","volume":"53","author":"Aydin S","year":"2025","journal-title":"J Int Med Res"},{"key":"e_1_2_11_50_1","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm S","year":"1979","journal-title":"Scand J Stat"},{"key":"e_1_2_11_51_1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","article-title":"Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease","volume":"64","author":"Ikonomovic MD","year":"2007","journal-title":"Arch Neurol"},{"key":"e_1_2_11_52_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease","volume":"40","author":"Kuhl DE","year":"1996","journal-title":"Ann Neurol"},{"key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-019-0717-3","article-title":"Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive decline","volume":"7","author":"Liu AKL","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"e_1_2_11_54_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky ST","year":"2002","journal-title":"Ann Neurol"},{"key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-024-00749-1","article-title":"Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease","volume":"19","author":"Shantaraman A","year":"2024","journal-title":"Mol Neurodegener"},{"key":"e_1_2_11_56_1","first-page":"173","volume-title":"The fate of the brain cholinergic neurons in neurodegenerative diseases","author":"Pepeu G","year":"2017"},{"key":"e_1_2_11_57_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.neuropsych.19070165","article-title":"Topography of cholinergic changes in dementia with lewy bodies and key neural network hubs","volume":"32","author":"Kanel P","year":"2020","journal-title":"J Neuropsychiat Clin Neurosci"},{"key":"e_1_2_11_58_1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen NI","year":"2015","journal-title":"JAMA Neurol"},{"key":"e_1_2_11_59_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.parkreldis.2021.09.018","article-title":"Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: an exploratory PET imaging study with [18F]\u2010FEOBV","volume":"91","author":"Legault\u2010Denis C","year":"2021","journal-title":"Parkins Related Disord"},{"issue":"2","key":"e_1_2_11_60_1","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab109","article-title":"Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease","volume":"3","author":"Bohnen NI","year":"2021","journal-title":"Brain Commun"},{"key":"e_1_2_11_61_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(86)91401-0","article-title":"Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non\u2010demented patients with Parkinson's disease","volume":"362","author":"Ruberg M","year":"1986","journal-title":"Brain Res"},{"key":"e_1_2_11_62_1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2014.04.032","article-title":"Where attention falls: increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function","volume":"257","author":"Sarter M","year":"2014","journal-title":"Exp Neurol"},{"key":"e_1_2_11_63_1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy\u2010 and Alzheimer\u2010type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta Y","year":"2011","journal-title":"Brain"},{"key":"e_1_2_11_64_1","doi-asserted-by":"crossref","unstructured":"HelyMA ReidWG AdenaMA HallidayGM MorrisJG.The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.2008:837\u2010844.","DOI":"10.1002\/mds.21956"},{"key":"e_1_2_11_65_1","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha\u2010synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease","volume":"54","author":"Hurtig HI","year":"2000","journal-title":"Neurology"},{"key":"e_1_2_11_66_1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of \u03b1\u2010synuclein and A\u03b2 in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer PT","year":"2012","journal-title":"Arch Neurol"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.71868","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/alz.71868","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.71868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:54:45Z","timestamp":1791294885000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.71868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/alz.71868"],"URL":"https:\/\/doi.org\/10.1002\/alz.71868","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2025-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71868"}}